GlassScriptPhysician profile
Heather Goodhile
NPI 1053823427
$1,466.99
in general payments reported to CMS, 2019-2025
18 companies · $643 in 2025
The $643 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $272 · 2022: $199 · 2023: $156 · 2024: $197 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $542.13 | 2021-2025 | Prialt |
| Abbott Laboratories | $203.29 | 2021-2023 | Proclaim |
| Boston Scientific Corporation | $186.91 | 2025 | General - Pain Management, Intracept |
| Collegium Pharmaceutical, INC. | $103.47 | 2022-2025 | Belbuca, Xtampza |
| Nalu Medical, INC. | $61.67 | 2025 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $51.98 | 2021-2023 | Ztlido |
| Spr Therapeutics, INC | $47.18 | 2024-2025 | Sprint Pns System |
| Abbvie INC. | $40.31 | 2025 | |
| Averitas Pharma INC. | $37.01 | 2025 | Qutenza |
| Virtus Pharmaceuticals LLC | $32.58 | 2024-2025 | Levorphanol Tartrate |
| Medtronic, INC. | $28.30 | 2021 | |
| Nevro Corp. | $25.05 | 2022 | |
| Appliedvr INC | $23.68 | 2025 | Relievrx |
| Vertex Pharmaceuticals Incorporated | $18.97 | 2025 | |
| Grt US Holding, INC. | $18.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Owp Pharmaceuticals, INC. | $17.07 | 2022 | |
| Si-Bone, INC. | $15.34 | 2023 | |
| Biodelivery Sciences International, INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Goodhile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.